MAP2K7 and non-small cell lung carcinoma: Interestingly, we demonstrated that NLOC-015A, a novel multitarget small molecule suppresses the proliferation and oncogenic phenotypes of NSCLC via inhibiting the EGFR, mTOR, MEK, and YAP1 signaling network.